BGF MDI (budesonide/glycopyrronium/formoterol)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BGF MDI (budesonide/glycopyrronium/formoterol), covering 2025-08-13 to 2025-08-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Pharmacokinetics and Safety of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-Generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a Spacer [Phase 1]